Brawn Biotech Ltd

NSE: BSE: 530207

₹21.66

(5.00%)

Sat, 26 Sept 2026, 03:02 am

MTF 5xInvest in Brawn Biotech Ltd with 5x Leverage Buy with MTF

Market Cap (in Cr)6.84

PE Ratio7.57

Dividend0

Health Technology

Pharmaceuticals: Major

24.5K

Brawn Biotech News

Brawn Biotech returns to profit in FY26

Brawn Biotech reported a net profit of ₹94.06 lakh for FY26, recovering from a loss of ₹179.81 lakh in the previous year.

29 May 2026

companies

Brawn Biotech board meets May 29

Brawn Biotech Ltd board meets on May 29, 2026 to consider Q4 and FY26 audited results. Trading window closes till May 31.

21 May 2026

companies

Brawn Biotech Declares Non-Applicability of SEBI LC Rules

Brawn Biotech Limited confirms it does not qualify as Large Corporate under SEBI framework with NIL outstanding borrowings as on March 31, 2025, making debt security regulations inapplicable.

13 Apr 2026

companies

Brawn Biotech Files Q4FY26 Compliance Certificate

Brawn Biotech Limited submitted its quarterly compliance certificate under SEBI Depositories Regulations for the quarter ended March 31, 2026, confirming proper dematerialisation processes.

08 Apr 2026

companies

Brawn Biotech Appoints New Auditors for FY 2025-26

Brawn Biotech Limited's board approved the appointment of Mr. Viney as Secretarial Auditor and M/s Sahil Pasricha & Associates as Internal Auditors for financial year 2025-26, effective March 25, 2026.

25 Mar 2026

companies

Showing 1–5 of 12

Rows per page:

Market Current News

XTRANET TECHNOLOGIES LIMITED

Xtranet Technologies updates CIN and listing status

Xtranet Technologies Limited updated its Corporate Identification Number and MCA listing status to 'Yes' following equity share listings on BSE and NSE.

25 Sept 2026

ipo

PRESTIGE ESTATES PROJECTS LTD.

Prestige Estates subsidiary PHVL withdraws draft IPO prospectus

Prestige Estates Projects' subsidiary PHVL has cancelled its Draft Red Herring Prospectus citing strategic reasons and uncertain market conditions. A new prospectus may be filed later.

25 Sept 2026

ipo

Runwal Enterprises IPO Day 1: Subscribed 0.03x

Runwal Enterprises IPO sees muted demand on Day 1 with overall subscription at 0.03x. QIB interest remains negligible while Retail leads category-wise response.

25 Sept 2026

ipo

Pooja Logistics IPO Day 3: Subscribed 0.59x

Pooja Logistics IPO sees sluggish demand on final day with overall subscription at 0.59x. Retail leads at 0.92x while QIB interest remains zero.

25 Sept 2026

ipo

Swastika Infra IPO Day 3: Subscribed 2.1x

Swastika Infra IPO closed Day 3 with overall subscription at 2.1x. Retail demand led at 2.2x, while QIB interest remained steady at 1x.

25 Sept 2026

ipo

Showing 1–5 of 94418

Rows per page: